Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	collagen binding	GPC1 COL6A1 MAP1A NID1 SMAD4 CRTAP	3.32e-05	81	150	6	GO:0005518
GeneOntologyMolecularFunction	diacylglycerol-dependent, calcium-independent serine/threonine kinase activity	PRKCD PRKCH	1.67e-04	3	150	2	GO:0004699
GeneOntologyBiologicalProcess	cell surface receptor protein tyrosine kinase signaling pathway	GPC1 RALA RALB COL6A1 FAT4 AHI1 MYO1C TSC2 CUL5 ZFYVE28 CD3E EFNA2 SOCS5 FIBP PRKCD AKT2 GNAI2 MUSK MVB12B KLB	3.66e-07	747	147	20	GO:0007169
GeneOntologyBiologicalProcess	enzyme-linked receptor protein signaling pathway	GPC1 RALA RALB COL6A1 FAT4 AHI1 MYO1C FNTA TSC2 DDX5 CUL5 ZFYVE28 CD3E EFNA2 SOCS5 FIBP PRKCD AKT2 GNAI2 MUSK SMAD4 MVB12B KLB	1.12e-05	1186	147	23	GO:0007167
GeneOntologyBiologicalProcess	mitochondrial fission	RALA PGAM5 PPARGC1A MIEF1 MTFR2	3.10e-05	51	147	5	GO:0000266
GeneOntologyBiologicalProcess	response to activity	COL6A1 ABCC9 GCG KDM6B PPARGC1A CXCR4	4.50e-05	90	147	6	GO:0014823
Domain	Myosin_TH1	MYO1C MYO1D MYO1B	1.74e-05	7	150	3	PF06017
Domain	Myosin_TH1	MYO1C MYO1D MYO1B	1.74e-05	7	150	3	IPR010926
Domain	TH1	MYO1C MYO1D MYO1B	1.74e-05	7	150	3	PS51757
Domain	SLIDE	SMARCA5 SMARCA1	6.41e-05	2	150	2	IPR015195
Domain	ISWI_HAND-dom	SMARCA5 SMARCA1	6.41e-05	2	150	2	IPR015194
Domain	SLIDE	SMARCA5 SMARCA1	6.41e-05	2	150	2	PF09111
Domain	HAND	SMARCA5 SMARCA1	6.41e-05	2	150	2	PF09110
Domain	Ral	RALA RALB	6.41e-05	2	150	2	IPR028412
Domain	ISWI	SMARCA5 SMARCA1	6.41e-05	2	150	2	IPR029915
Domain	DBINO	SMARCA5 SMARCA1	1.91e-04	3	150	2	IPR020838
Domain	DBINO	SMARCA5 SMARCA1	1.91e-04	3	150	2	PF13892
Domain	Pkinase_C	SGK2 PRKCD PRKCH AKT2	2.15e-04	37	150	4	IPR017892
Domain	-	ATR TTC16 KDM6B IFIT1 SH3TC1 TTC12 CLTC CRTAP	2.73e-04	207	150	8	1.25.40.10
Domain	Pkinase_C	SGK2 PRKCD PRKCH AKT2	3.53e-04	42	150	4	PF00433
Domain	Prot_kin_PKC_delta	PRKCD PRKCH	3.80e-04	4	150	2	IPR014376
Domain	TPR-like_helical_dom	ATR TTC16 KDM6B IFIT1 SH3TC1 TTC12 CLTC CRTAP	5.99e-04	233	150	8	IPR011990
Domain	GLYCOSYL_HYDROL_F1_1	LCT KLB	6.31e-04	5	150	2	PS00572
Domain	Glyco_hydro_1	LCT KLB	6.31e-04	5	150	2	PF00232
Domain	GLYCOSYL_HYDROL_F1_2	LCT KLB	6.31e-04	5	150	2	PS00653
Domain	Glyco_hydro_1	LCT KLB	6.31e-04	5	150	2	IPR001360
Domain	CLIC	CLIC6 CLIC1	9.41e-04	6	150	2	IPR002946
Domain	Methyltransf_12	METTL6 FASN	9.41e-04	6	150	2	IPR013217
Domain	Methyltransf_12	METTL6 FASN	9.41e-04	6	150	2	PF08242
Domain	AGC-kinase_C	SGK2 PRKCD PRKCH AKT2	1.06e-03	56	150	4	IPR000961
Domain	AGC_KINASE_CTER	SGK2 PRKCD PRKCH AKT2	1.06e-03	56	150	4	PS51285
Domain	S_TK_X	SGK2 PRKCD PRKCH AKT2	1.06e-03	56	150	4	SM00133
Pathway	WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER	RALA RALB BCL2L11 NTN1 AKT2 SMAD4	1.87e-05	73	107	6	M39758
Pathway	WP_SILDENAFIL_TREATMENT	PDE4A PDE4D PPARGC1A AKT2	2.49e-05	23	107	4	M46455
Pathway	KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	CXCR4 AKT2 GNAI2	8.90e-05	12	107	3	M47558
Pathway	KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY	CXCR4 AKT2 GNAI2	8.90e-05	12	107	3	M47559
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	GPC1 COL6A1 FAT4 VMA21 ATR DNAJC18 TSC2 ZZEF1 TXNDC11 STT3A TFPI SLC30A7 FOXRED2 ARSA CLIC1 CXCR4 MICAL2 FANCI NID1 GNAI2 C1QTNF6 CHPF PLXNA1 CRTAP	4.02e-10	1201	150	24	35696571
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	RALA COL6A1 RARS1 MYO1C MYO1D SERPINF1 MYO1B CLIC6 PKD1L3 DDX5 FASN CLIC1 CLTC NID1 PRKCD PRKCH GNAI2 LAMTOR1 SERPINA5 MVB12B	1.72e-08	1016	150	20	19056867
Pubmed	LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.	GPC1 RALA RALB RARS1 MYO1C MYO1D MYO1B PGAM5 DDX5 FASN CLIC1 PKP3 CLTC GNAI2	2.48e-07	580	150	14	35676659
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PDE4A NUP85 BCL2L11 TSC2 KDM6B ZZEF1 FASN MGAT1 EFNA2 SLC12A4 SH3TC1 FAM83F FANCI AKT2 CHPF DOCK6 MED12 PLXNA1 MVB12B	3.23e-07	1105	150	19	35748872
Pubmed	Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.	COL6A1 RARS1 NUP85 HEPH TXNDC11 STT3A DDX5 FASN FOXRED2 CLIC1 CLTC CHPF PLXNA1 CRTAP	4.80e-07	613	150	14	22268729
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	GPC1 RALA SMARCA5 RARS1 NUP85 MYO1C MYO1D MYO1B YTHDC1 PGAM5 STT3A DDX5 RALY FASN FAM83F CLIC1 PKP3 CLTC SMARCA1 GNAI2	5.23e-07	1257	150	20	36526897
Pubmed	SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis.	RARS1 NUP85 L3MBTL2 PEX3 ZZEF1 STT3A DDX5 SLC30A7 FASN VANGL1 FANCI MACO1 CLTC CRTAP	1.09e-06	657	150	14	36180527
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	GPC1 SMARCA5 RARS1 MYO1C L3MBTL2 MYO1B DCK PGAM5 DDX5 RALY ALKBH1 FASN CLIC1 MICAL2 FANCI CLTC SMARCA1 PRKCD GNAI2 MED12	1.62e-06	1353	150	20	29467282
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	GPC1 SMARCA5 RARS1 MYO1C MYO1B IFIT1 PGAM5 DDX5 RALY FASN CLIC1 CLTC SMARCA1 GNAI2 SCAI	2.25e-06	803	150	15	36517590
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	PGS1 AHI1 RARS1 NUP85 MYO1C TSC2 DDX5 SLC12A4 VANGL1 FANCI PKP3 MIEF1 GNAI2 TANGO2 CRBN SMAD4	2.73e-06	925	150	16	28986522
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SMARCA5 MYO1B KDM6B DDX5 FASN PKP3 CLTC GNAI2 MED12	3.04e-06	272	150	9	31010829
Pubmed	Reversible oxidation of phosphatase and tensin homolog (PTEN) alters its interactions with signaling and regulatory proteins.	GPC1 MYO1C MYO1D MYO1B FASN GNAI2	4.42e-06	98	150	6	26561776
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FAT4 NUP85 INTS7 MORC2 IFIT1 STT3A DDX5 RALY FASN RGS6 SLC12A4 FIG4 GNAI2 TRIM47	5.33e-06	754	150	14	35906200
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	GPC1 SMARCA5 NUP85 MYO1C PGAM5 DDX5 TFPI RALY CLIC1 CLTC SMARCA1 GNAI2 CRTAP	6.26e-06	660	150	13	32780723
Pubmed	Interactome and Proteome Dynamics Uncover Immune Modulatory Associations of the Pathogen Sensing Factor cGAS.	SMARCA5 MYO1C MAP1A IFIT1 RALY SLC12A4 SMARCA1 LAMTOR1	7.14e-06	228	150	8	30471916
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RALA SMARCA5 RARS1 NUP85 MYO1D MYO1B PGAM5 DDX5 RALY TAF6L FASN CLIC1 VANGL1 PKP3 CLTC GNAI2	9.77e-06	1024	150	16	24711643
Pubmed	Nuclear lamina genetic variants, including a truncated LAP2, in twins and siblings with nonalcoholic fatty liver disease.	RARS1 MYO1C MYO1D MYO1B PGAM5 DDX5 FASN CLTC	1.17e-05	244	150	8	28902428
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	VMA21 APBB2 TSC2 SLC30A7 SLC12A4 FIG4 VANGL1 MACO1 LAMTOR1 DOCK6 PLXNA1	1.29e-05	504	150	11	34432599
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	RALA SMARCA5 RARS1 MYO1C ATR MYO1D MYO1B PGAM5 STT3A DDX5 RALY FASN CLIC1 CXCR4 FANCI CLTC SMARCA1 PRKCD PLXNA1	1.30e-05	1425	150	19	30948266
Pubmed	Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).	GPC1 RALA COL6A1 GBP6 MYO1C MYO1D MYO1B MGAT1 CLTC GNAI2	1.45e-05	417	150	10	19199708
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	NUP85 MYO1C HLA-DPB1 MYO1B TSC2 IFIT1 PGAM5 STT3A RALY CUL5 SLC30A7 FASN CLIC1 CXCR4 FANCI MACO1 CLTC HOOK2 LAMTOR1	1.51e-05	1440	150	19	30833792
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	RALA RALB SMARCA5 NUP85 MYO1C MYO1D TTC16 DNAJC18 MYO1B PGAM5 DDX5 RALY FASN SLC12A4 UMODL1 PCDHGA12 CLTC SMARCA1 GNAI2	1.54e-05	1442	150	19	35575683
Pubmed	Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium.	CXCR4 PRKCD PRKCH	1.68e-05	12	150	3	11141237
Pubmed	Ral GTPases in Schwann cells promote radial axonal sorting in the peripheral nervous system.	RALA RALB	1.85e-05	2	150	2	31201267
Pubmed	RalGTPases contribute to Schwann cell repair after nerve injury via regulation of process formation.	RALA RALB	1.85e-05	2	150	2	31201266
Pubmed	RalA and RalB differentially regulate development of epithelial tight junctions.	RALA RALB	1.85e-05	2	150	2	22013078
Pubmed	Differential involvement of RalA and RalB in colorectal cancer.	RALA RALB	1.85e-05	2	150	2	22790202
Pubmed	Tissue-specific expression of GTPas RalA and RalB during embryogenesis and regulation by epithelial-mesenchymal interaction.	RALA RALB	1.85e-05	2	150	2	11025226
Pubmed	RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival.	RALA RALB	1.85e-05	2	150	2	12856001
Pubmed	SDF-1α degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory.	BCL2L11 CXCR4	1.85e-05	2	150	2	22802411
Pubmed	TRIM47 promotes glioma angiogenesis by suppressing Smad4.	TRIM47 SMAD4	1.85e-05	2	150	2	36203070
Pubmed	Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.	CXCR4 SMAD4	1.85e-05	2	150	2	22377565
Pubmed	Phosphorylation of TSC2 by PKC-δ reveals a novel signaling pathway that couples protein synthesis to mTORC1 activity.	TSC2 PRKCD	1.85e-05	2	150	2	30684133
Pubmed	Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.	RALA RALB	1.85e-05	2	150	2	26216878
Pubmed	Localization of the rat myosin I molecules myr 1 and myr 2 and in vivo targeting of their tail domains.	MYO1C MYO1B	1.85e-05	2	150	2	8719884
Pubmed	RalA and RalB proteins are ubiquitinated GTPases, and ubiquitinated RalA increases lipid raft exposure at the plasma membrane.	RALA RALB	1.85e-05	2	150	2	22700969
Pubmed	Coding sequences of human ralA and ralB cDNAs.	RALA RALB	1.85e-05	2	150	2	2662142
Pubmed	TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.	TRIM47 SMAD4	1.85e-05	2	150	2	30979374
Pubmed	Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes.	PDE4A PDE4D	1.85e-05	2	150	2	9520403
Pubmed	Distinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.	RALA RALB	1.85e-05	2	150	2	18756269
Pubmed	Direct binding of RalA to PKCη and its crucial role in morphological change during keratinocyte differentiation.	RALA PRKCH	1.85e-05	2	150	2	21346190
Pubmed	CXCR4-independent rescue of the myeloproliferative defect of the Gata1low myelofibrosis mouse model by Aplidin.	GATA1 CXCR4	1.85e-05	2	150	2	20458749
Pubmed	Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.	RALA RALB	1.85e-05	2	150	2	17875936
Pubmed	KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression.	KDM6B CXCR4	1.85e-05	2	150	2	36564369
Pubmed	Ral GTPases regulate cell-mediated cytotoxicity in NK cells.	RALA RALB	1.85e-05	2	150	2	21810610
Pubmed	RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis.	RALA RALB	1.85e-05	2	150	2	34096503
Pubmed	Ral GTPases in tumorigenesis: emerging from the shadows.	RALA RALB	1.85e-05	2	150	2	23830877
Pubmed	Expression of fatty acid synthase is regulated by PGC‑1α and contributes to increased cell proliferation.	PPARGC1A FASN	1.85e-05	2	150	2	29130104
Pubmed	Protein Kinase C (Pkc)-δ Mediates Arginine-Induced Glucagon Secretion in Pancreatic α-Cells.	GCG PRKCD	1.85e-05	2	150	2	35409362
Pubmed	Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.	RALA RALB	1.85e-05	2	150	2	17174914
Pubmed	Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.	RALA RALB	1.85e-05	2	150	2	20679536
Pubmed	Characterization and Genomic Localization of a SMAD4 Processed Pseudogene.	SMAD4 SCAI	1.85e-05	2	150	2	28867604
Pubmed	Expression of ral GTPases, their effectors, and activators in human bladder cancer.	RALA RALB	1.85e-05	2	150	2	17606711
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	PDE4A MYO1C MYO1D MYO1B MORC2 PGAM5 DDX5 RALY FASN PKP3 CLTC GNAI2	1.88e-05	626	150	12	33644029
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	VMA21 NUP85 MYO1C MYO1D TTLL5 PEX3 TSC2 ZZEF1 IFIT1 PGAM5 STT3A RALY VANGL1 MACO1 CLTC MIEF1 PRKCD PRKCH MTFR2	2.55e-05	1496	150	19	32877691
Pubmed	Landscape of the SOX2 protein-protein interactome.	COL6A1 SMARCA5 MYO1C MYO1B DDX5 GNAI2	2.88e-05	136	150	6	21280222
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	GPC1 SMARCA5 RARS1 MYO1C MYO1D MYO1B YTHDC1 PGAM5 DDX5 RALY FASN CLIC1 MICAL2 PKP3 CLTC GNAI2 MED12	2.91e-05	1247	150	17	27684187
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	PDE4D MYO1C ATR MYO1B FASN CLTC DOCK6	2.93e-05	202	150	7	33005030
Pubmed	The deubiquitylase USP33 discriminates between RALB functions in autophagy and innate immune response.	RALA RALB MYO1C	3.44e-05	15	150	3	24056301
Pubmed	A QUICK screen for Lrrk2 interaction partners--leucine-rich repeat kinase 2 is involved in actin cytoskeleton dynamics.	MYO1C MYO1D MYO1B GNAI2	3.60e-05	43	150	4	20876399
Pubmed	CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.	MYO1C MYO1D MYO1B DDX5 FASN CLTC GNAI2 LAMTOR1	3.82e-05	288	150	8	31501420
Pubmed	A synthetic peptide with sequence identity to the transmembrane protein GP41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx.	CD3E PRKCD PRKCH	4.23e-05	16	150	3	1832084
Pubmed	A genome annotation-driven approach to cloning the human ORFeome.	L3MBTL2 MORC2 FOXRED2 ARSA SYNGR1 C1QTNF6 TANGO2 BRD1	4.42e-05	294	150	8	15461802
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	GPC1 RARS1 MYO1C MYO1B SYF2 STT3A DDX5 SLC30A7 FASN FOXRED2 PLPP2 VANGL1 PKP3 CLTC GNAI2 LAMTOR1 CRTAP	4.75e-05	1297	150	17	33545068
Pubmed	Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways.	YTHDC1 IFIT1 FASN CLIC1 CLTC SMAD4	5.38e-05	152	150	6	16009940
Pubmed	A trimeric Rab7 GEF controls NPC1-dependent lysosomal cholesterol export.	RALA RARS1 MYO1C MYO1B STT3A SLC30A7 PRKCD GNAI2 LAMTOR1	5.50e-05	392	150	9	33144569
Pubmed	Effect of epinephrine deficiency on cold tolerance and on brown adipose tissue.	PNMT PPARGC1A	5.53e-05	3	150	2	20619316
Pubmed	H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts.	COL6A1 SOCS5	5.53e-05	3	150	2	33391546
Pubmed	Histone demethylase Jmjd3 regulates osteoblast apoptosis through targeting anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bim.	BCL2L11 KDM6B	5.53e-05	3	150	2	26795455
Pubmed	Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.	RALA RALB	5.53e-05	3	150	2	23063435
Pubmed	Myosin I can act as a molecular force sensor.	MYO1C MYO1B	5.53e-05	3	150	2	18599791
Pubmed	Post-translational regulation of PGC-1α modulates fibrotic repair.	PPARGC1A AKT2	5.53e-05	3	150	2	34038004
Pubmed	The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).	PDE4A PDE4D	5.53e-05	3	150	2	24555506
Pubmed	Interaction of tubby-like protein-1 (Tulp1) and microtubule-associated protein (MAP) 1A and MAP1B in the mouse retina.	MAP1A TULP1	5.53e-05	3	150	2	24664738
Pubmed	GLP-1 contributes to increases in PGC-1α expression by downregulating miR-23a to reduce apoptosis.	GCG PPARGC1A	5.53e-05	3	150	2	26315270
Pubmed	Differential expression and function of phosphodiesterase 4 (PDE4) subtypes in human primary CD4+ T cells: predominant role of PDE4D.	PDE4A PDE4D	5.53e-05	3	150	2	17404263
Pubmed	Mouse Platelet Ral GTPases Control P-Selectin Surface Expression, Regulating Platelet-Leukocyte Interaction.	RALA RALB	5.53e-05	3	150	2	29437579
Pubmed	Specific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophages.	PDE4A PDE4D	5.53e-05	3	150	2	16034090
Pubmed	Novel BMP1, CRTAP, and SERPINF1 variants causing autosomal recessive osteogenesis imperfecta.	SERPINF1 CRTAP	5.53e-05	3	150	2	35703132
Pubmed	Ral-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signalling.	RALA RALB	5.53e-05	3	150	2	27269287
Pubmed	Mammalian myosin I alpha, I beta, and I gamma: new widely expressed genes of the myosin I family.	MYO1C MYO1B	5.53e-05	3	150	2	8449986
Pubmed	Nidogen/entactin (Nid) maps to the proximal end of mouse chromosome 13 linked to beige (bg) and identifies a new region of homology between mouse and human chromosomes.	RALA NID1	5.53e-05	3	150	2	1672300
Pubmed	Binding kinetics of human ISWI chromatin-remodelers to DNA repair sites elucidate their target location mechanism.	SMARCA5 SMARCA1	5.53e-05	3	150	2	21738833
Pubmed	Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease.	GATA1 CXCR4	5.53e-05	3	150	2	18206727
Pubmed	Cloning and characterization of the murine Imitation Switch (ISWI) genes: differential expression patterns suggest distinct developmental roles for Snf2h and Snf2l.	SMARCA5 SMARCA1	5.53e-05	3	150	2	11359880
Pubmed	Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination.	ATR FANCI	5.53e-05	3	150	2	34828369
Pubmed	Protein kinase C delta and eta differently regulate the expression of loricrin and Jun family proteins in human keratinocytes.	PRKCD PRKCH	5.53e-05	3	150	2	20184865
Pubmed	Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation.	PDE4A PDE4D	5.53e-05	3	150	2	15585880
Pubmed	Ral GTPase-activating protein regulates the malignancy of pancreatic ductal adenocarcinoma.	RALA RALB	5.53e-05	3	150	2	34009715
Pubmed	H3K27me3 regulates BMP activity in developing spinal cord.	KDM6B SMAD4	5.53e-05	3	150	2	20667911
Pubmed	An allele of microtubule-associated protein 1A (Mtap1a) reduces photoreceptor degeneration in Tulp1 and Tub Mutant Mice.	MAP1A TULP1	5.53e-05	3	150	2	22323461
Pubmed	Cyclic AMP phosphodiesterases are localized in regions of the mouse brain associated with reinforcement, movement, and affect.	PDE4A PDE4D	5.53e-05	3	150	2	10213096
Pubmed	Live-cell single-molecule imaging reveals clathrin and caveolin-1 dependent docking of SMAD4 at the cell membrane.	CLTC SMAD4	5.53e-05	3	150	2	24211445
Pubmed	Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.	PDE4A PDE4D	5.53e-05	3	150	2	18508768
Pubmed	Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.	PRKCD AKT2	5.53e-05	3	150	2	21618512
Pubmed	The exocyst complex binds the small GTPase RalA to mediate filopodia formation.	RALA RALB	5.53e-05	3	150	2	11744922
Pubmed	RalA and RalB relocalization to depolarized mitochondria depends on clathrin-mediated endocytosis and facilitates TBK1 activation.	RALA RALB	5.53e-05	3	150	2	30995277
Pubmed	Constitutive phosphorylation of GATA-1 at serine²⁶ attenuates the colony-forming activity of erythrocyte-committed progenitors.	BCL2L11 GATA1	5.53e-05	3	150	2	23717580
Pubmed	Paradoxical effects of increased expression of PGC-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism.	PPARGC1A AKT2	5.53e-05	3	150	2	19066218
Pubmed	Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.	RALA RALB	5.53e-05	3	150	2	17709381
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	MYO1C SERPINF1 MFSD6L KDM6B KCTD11 ZZEF1 NTN1	1.52e-04	346	150	7	chr17p13
GeneFamily	Myosins, class I	MYO1C MYO1D MYO1B	9.01e-06	8	100	3	1097
GeneFamily	Chloride intracellular channels	CLIC6 CLIC1	4.48e-04	6	100	2	307
GeneFamily	C2 domain containing protein kinases	PRKCD PRKCH	1.32e-03	10	100	2	835
ToppCell	Entopeduncular-Endothelial\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	MYO1C MYO1B TFPI CLIC1 PRKCD TRIM47 CRTAP	3.54e-06	188	150	7	94774652fd42bad5012356672ffac8b6d2c22d37
ToppCell	Globus_pallidus-Endothelial\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	MYO1C TFPI CLIC1 NID1 TRIM47 DOCK6 CRTAP	3.66e-06	189	150	7	ad7dc9d25edd68fb624380a082c389fe7d640e7d
ToppCell	Striatum-Endothelial\|Striatum / BrainAtlas - Mouse McCarroll V32	MYO1C ABCC9 TFPI NID1 TRIM47 DOCK6 CRTAP	3.66e-06	189	150	7	95ee3b6d7fbbfcf91c780dfcd0926acec05f0a2d
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A1 SERPINF1 ABCC9 CPB1 KDM6B TFPI NID1	4.50e-06	195	150	7	fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCell	5'-Adult-Appendix-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A1 SERPINF1 ABCC9 CPB1 KDM6B TFPI NID1	4.81e-06	197	150	7	ab5d3ebc73bd7cfc64381d14b92878b370205186
ToppCell	Healthy_donor-gd_T\|World / disease group, cell group and cell class (v2)	TTC16 ZFYVE28 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	4.97e-06	198	150	7	0c3475936f148f2c026501c61b43bcb94d320c48
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 PTX4 SERPINF1 NID1 C1QTNF6 CHPF CRTAP	4.97e-06	198	150	7	524305c5d7b1d53e86ec0af775efefa3e0955e47
ToppCell	COVID-19_Severe-CD8+_T_activated\|COVID-19_Severe / disease group, cell group and cell class	TTC16 HLA-DPB1 DDX5 CD3E CXCR4 SYNGR1 PRKCH	5.14e-06	199	150	7	a16b961996291bd5958c3851b7fdd7b45c53e19b
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	TTC16 HLA-DPB1 IFIT1 DDX5 CD3E CLIC1 SYNGR1	5.31e-06	200	150	7	b7f80b2db07119069fbf3d245cf1ad79e8648bab
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate\|3m / Sample Type, Dataset, Time_group, and Cell type.	ERICH1 RARS1 MAP1A PPP1R3E KDM6B MIEF1 CHPF	5.31e-06	200	150	7	cbd0b9188a94778ffa539912aeb2a4378f0ab88f
ToppCell	Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1\|Hippocampus / BrainAtlas - Mouse McCarroll V32	COL6A1 SERPINF1 CPB1 FANCI NID1 MUSK	6.28e-06	134	150	6	b959899c89d3a0363a3cd2309155280e0fe5ba88
ToppCell	Healthy_donor-MAIT\|World / disease group, cell group and cell class (v2)	PDE4D CD3E PLPP2 CXCR4 PRKCH BRD1	2.59e-05	172	150	6	6524eb2be1c78700ad367e62624a4d7eb48b54f0
ToppCell	(0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts\|(0)_Normal/No_Treatment / Stress and Cell class	GPC1 MYO1D SERPINF1 MYO1B STT3A C1QTNF6	2.68e-05	173	150	6	c2a0f674681836b5a868c13f67caa7d555ef6519
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_B-plasmablast-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	MYO1D PLEKHG7 TXNDC11 PLPP2 FANCI CHPF	2.86e-05	175	150	6	89bf89466191da14896ed8928027f5b911436c22
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	COL6A1 SERPINF1 ABCC9 SLC12A4 NTN1 C1QTNF6	2.95e-05	176	150	6	08f94b78b27feeb113dbfadbfa7fe34d08b2809b
ToppCell	facs-MAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE4D CD3E CXCR4 PKP3 PRKCH CRBN	2.95e-05	176	150	6	359a57aea89d8e6776eaefb0c3553a0dbcad5e58
ToppCell	5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MFSD6L TSC2 KCNC3 FAM83F AKT2 PLXNA1	3.05e-05	177	150	6	e1e45956887371b1c18f1eb479dd930031497520
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERICH1 BCL2L11 PGAP6 SGK2 PPARGC1A RGS6	3.25e-05	179	150	6	2e49b215b71438400aebb483f2c2c08d5e956961
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ERICH1 BCL2L11 PGAP6 SGK2 PPARGC1A RGS6	3.25e-05	179	150	6	d0fa700648db8ce76a8aa689879a25048299fa40
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 SERPINF1 ABHD16B NID1 NTN1 C1QTNF6	3.35e-05	180	150	6	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A1 ABCC9 MYO1B TFPI CLVS2 NID1	3.67e-05	183	150	6	8a799807fbf24456a9811e0c64068187940a2f71
ToppCell	droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT4 MTERF1 SERPINF1 APBB2 MICAL2 TRIM47	3.67e-05	183	150	6	351d575339038bd4a66f408da518c567444208e8
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1D APBB2 MYO1B PPARGC1A MICAL2 SCAI	3.79e-05	184	150	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	(2)_5-FU-(4)_COL2.3+_osteoblasts\|World / Stress and Cell class	GPC1 MYO1D SERPINF1 MICAL2 C1QTNF6 CRTAP	3.79e-05	184	150	6	684d05340a3dfb8aa08b881516a37f9627a10448
ToppCell	facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PDE4A PPP1R3E SERPINF1 ABCC9 PCDHGA12 NID1	3.79e-05	184	150	6	d754c3de621429b220ae4ac426cdfc619e848462
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO1D APBB2 MYO1B PPARGC1A MICAL2 SCAI	3.79e-05	184	150	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	COVID-19_Severe-CD4+_CTL\|COVID-19_Severe / Disease condition and Cell class	TTC16 HLA-DPB1 IFIT1 CD3E CLIC1 CXCR4	4.02e-05	186	150	6	728d81405fdcd137097433dd676b26519185e916
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	APBB2 ABCC9 MYO1B CLVS2 NID1 DOCK6	4.02e-05	186	150	6	888e85a025bd982d36c910db0f5a3385b1ca3b28
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE4D BCL2L11 HLA-DPB1 CD3E SYNGR1 MVB12B	4.14e-05	187	150	6	d17352f769c3c66601b65d060626eecff41b0482
ToppCell	B_cells-Plasma_cells_and_plasmablasts\|World / Immune cells in Kidney/Urine in Lupus Nephritis	MYO1D TPTE2 TXNDC11 ARSA SIX5 CHPF	4.14e-05	187	150	6	9325cadd5f2c667d526696899e7aa36a98226d4b
ToppCell	droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A1 SERPINF1 ABCC9 TULP1 NTN1 C1QTNF6	4.14e-05	187	150	6	ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9
ToppCell	Frontal_cortex-Endothelial\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GBP6 TFPI NID1 TRIM47 DOCK6 CRTAP	4.27e-05	188	150	6	a43392dbd10fc7dbfb31be39b8af8a7ea121c894
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 NID1 NTN1 C1QTNF6	4.40e-05	189	150	6	f0a2d4ef9896d764971ebbc6952510c128bb76e8
ToppCell	droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 NID1 NTN1 C1QTNF6	4.40e-05	189	150	6	378f26f751ab4b470948c35dd8347de72dd12ff7
ToppCell	facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERPINF1 ABCC9 KCTD11 NID1 NTN1 MUSK	4.53e-05	190	150	6	990ac07f4b0a22041daac7502f74fafd6d258cba
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ABCC9 TFPI MICAL2 NID1 MUSK	4.53e-05	190	150	6	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERPINF1 ABCC9 KCTD11 NID1 NTN1 MUSK	4.53e-05	190	150	6	fc9bbe5e6e0ec3cfa47bf479d8b09a0fc53169cc
ToppCell	facs-Thymus-Flowthrough-24m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SERPINF1 ABCC9 KCTD11 NID1 NTN1 MUSK	4.53e-05	190	150	6	39ecdf8815e235771132684dfc1aff1917e20965
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ABCC9 TFPI MICAL2 NID1 MUSK	4.53e-05	190	150	6	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO1D APBB2 MYO1B PPARGC1A MICAL2 SCAI	4.53e-05	190	150	6	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL6A1 SERPINF1 DDX5 TFPI NID1 MUSK	4.53e-05	190	150	6	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	Thalamus\|World / BrainAtlas - Mouse McCarroll V32	UMODL1 VANGL1 PRKCD PRKCH RAB37	4.59e-05	116	150	5	5ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL6A1 SERPINF1 DDX5 TFPI NID1 MUSK	4.66e-05	191	150	6	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	mild_COVID-19-gd_T\|mild_COVID-19 / disease group, cell group and cell class (v2)	ZFYVE28 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	4.66e-05	191	150	6	0e43c097b92aaa831811d60e033262999e79dcd7
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	PDE4D MYO1D MYO1B CLIC6 MICAL2 SCAI	4.80e-05	192	150	6	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	18-Distal-Epithelial-Secretory_progenitor\|Distal / Age, Tissue, Lineage and Cell class	SERPINF1 MFSD6L CLIC6 PLPP2 UMODL1 PKP3	4.80e-05	192	150	6	9fae988ecd2ef1231bfd42a678a4903517694cbe
ToppCell	mild_COVID-19-gd_T\|World / disease group, cell group and cell class (v2)	PDE4D ZFYVE28 CD3E PLPP2 CXCR4 PRKCH	4.80e-05	192	150	6	6912283dbd73285b6e0c653b2dd34c31337b9f1e
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE4D BCL2L11 HLA-DPB1 CD3E PRKCH MVB12B	4.94e-05	193	150	6	778fcf8448e81fe18972d97ea8a30ab036d16fe5
ToppCell	367C-Myeloid-Dendritic-cDC2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RALA HLA-DPB1 SERPINF1 KDM6B DCK CXCR4	4.94e-05	193	150	6	940e9a419d0de1f9e72b5cc9c86684057003be58
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCG PGAP6 DDX5 CLTC GNAI2 CHPF	4.94e-05	193	150	6	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GCG PGAP6 DDX5 CLTC GNAI2 CHPF	4.94e-05	193	150	6	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	Control-Myeloid-cDC2\|Myeloid / Disease state, Lineage and Cell class	RALA PDE4A MYO1D HLA-DPB1 SERPINF1 CXCR4	4.94e-05	193	150	6	4cb938c346cc32ec122d11e6b9f25db20e0f7ff6
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	PDE4D HLA-DPB1 KDM6B IFIT1 CXCR4 BRD1	4.94e-05	193	150	6	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	metastatic_Lymph_Node-T/NK_cells-CD4+_Th\|metastatic_Lymph_Node / Location, Cell class and cell subclass	PDE4D DDX5 ZFYVE28 CD3E CXCR4 PRKCH	5.08e-05	194	150	6	1ce9b4c1fbdbc5e39c03adf7ffba3d0efea81862
ToppCell	facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 NID1 CHPF CRTAP	5.08e-05	194	150	6	da45811ba07d746e7cba7ed78882b5d98ac7397d
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE4D BCL2L11 HLA-DPB1 CD3E PRKCH MVB12B	5.08e-05	194	150	6	b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPC1 COL6A1 AHI1 MAP1A SYF2 CHPF	5.08e-05	194	150	6	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	Control-Myeloid-MoAM4\|Myeloid / Condition, Lineage and Cell class	RALA GBP6 MYO1D HLA-DPB1 SERPINF1 CXCR4	5.08e-05	194	150	6	7ab808dd1876b0eec2831caa16d04fd859b1dc50
ToppCell	medial-2-Hematologic-Plasmacytoid_Dendritic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BCL2L11 MAP1A SERPINF1 DCK SH3TC1 CXCR4	5.08e-05	194	150	6	d58be6454a0795d6771036a1620553a153861615
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	PDE4D BCL2L11 HLA-DPB1 CD3E PRKCH MVB12B	5.08e-05	194	150	6	64535db0420e53e4d777d2333b5051e63e8a3373
ToppCell	MS-CD8\|MS / Condition, Cell_class and T cell subcluster	TTC16 HLA-DPB1 CD3E CXCR4 PRKCH RAB37	5.08e-05	194	150	6	8dfeaa213403cedecb1976bfde1bac84f0155999
ToppCell	medial-Hematologic-Plasmacytoid_Dendritic\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BCL2L11 MAP1A SERPINF1 DCK SH3TC1 CXCR4	5.08e-05	194	150	6	bb36274d6fe2d18c545a17d3809f331586502d01
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	COL6A1 SERPINF1 DDX5 TFPI NID1 MUSK	5.08e-05	194	150	6	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	facs-BAT-Fat-3m-Mesenchymal\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 NID1 CHPF CRTAP	5.08e-05	194	150	6	76b8512fd92014b3ecc42b0a20d6d1df074cba2c
ToppCell	medial-Hematologic-Plasmacytoid_Dendritic-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BCL2L11 MAP1A SERPINF1 DCK SH3TC1 CXCR4	5.08e-05	194	150	6	0117cd68750153fd6b8978c8b4ce3589486d2b5f
ToppCell	MS-CD8-CD8_1\|MS / Condition, Cell_class and T cell subcluster	TTC16 HLA-DPB1 CD3E CXCR4 PRKCH RAB37	5.08e-05	194	150	6	9c05eb30c4b5c6fc410b83cb8aa8138bd46527c9
ToppCell	facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 NID1 CHPF CRTAP	5.08e-05	194	150	6	ef0fa9daecd3bf43c6cf56345928cacdbee19779
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-Exhausted_CD8+_T\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	HLA-DPB1 DDX5 ZFYVE28 CD3E CXCR4 PRKCH	5.23e-05	195	150	6	f2029195d5b655120a9e84074b2583e2d89c0a1d
ToppCell	Posterior_cortex-Endothelial\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TFPI VANGL1 NID1 TRIM47 DOCK6 CRTAP	5.23e-05	195	150	6	988e3449691cc228cb55e5e30355136c97b12262
ToppCell	Mild/Remission-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYO1D TXNDC11 STT3A MGAT1 ARSA CHPF	5.23e-05	195	150	6	52bdd609253613b7db75dccbc1c01c05e8d73f79
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TTC16 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	5.38e-05	196	150	6	aec2b11a6048048820271266fdc8b8d806da9993
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO1D APBB2 ABCC9 RGS6 MICAL2 NID1	5.38e-05	196	150	6	b8759e6231e0254797d6c30930407b79440c57bb
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TTC16 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	5.38e-05	196	150	6	aa0dc04f94a575cd442ee473b75a4f54268e4105
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	COL6A1 MAP1A MYO1D MICAL2 NTN1 SERPINA5	5.38e-05	196	150	6	24d64b67aa9b0e8215ad06f9101c1314b3483620
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABCC9 MYO1B IFIT1 TFPI CLIC1 NID1	5.38e-05	196	150	6	c16fbd23d9e117831b55ab3da5b08b22dd972432
ToppCell	severe-Lymphocytic-CD8_T_cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TTC16 HLA-DPB1 CD3E CXCR4 PRKCH MVB12B	5.38e-05	196	150	6	d83acd9abd7b296989b8ae09da63799e6877a149
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYO1C APBB2 MYO1B MICAL2 PLXNA1 SCAI	5.38e-05	196	150	6	eb68f7954e7c2f86d05e740e95b6e74805a6053f
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTC16 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	5.38e-05	196	150	6	ae9bf04531b9bda819608d90736c4405a6c3df41
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TTC16 HLA-DPB1 DDX5 CD3E CXCR4 PRKCH	5.38e-05	196	150	6	4e1f8828413896ab8a4ec92a89d6789e8e37e05a
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 GCG STT3A NID1	5.38e-05	196	150	6	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	Mild/Remission-Plasmablast\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYO1D TXNDC11 STT3A MGAT1 ARSA CHPF	5.38e-05	196	150	6	dcf0a804a79a05454658498d1f87320c7e079219
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A1 ABCC9 MYO1B TFPI MICAL2 NID1	5.38e-05	196	150	6	44e2df1b61e3819eae7e482bef0a733afe852d67
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL6A1 ABCC9 MYO1B TFPI MICAL2 NID1	5.38e-05	196	150	6	cb61757646653f89faba503cb5d99e5dd5197b4c
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-gd_T-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTC16 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	5.38e-05	196	150	6	502834a16d5ada93af7ab9af0c3dc652086964bd
ToppCell	Severe-Plasmablast\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	MYO1D TXNDC11 STT3A MGAT1 ARSA CHPF	5.38e-05	196	150	6	ee991f1d9936c656f4fbc2e0cec9e0166a34bc5b
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TTC16 HLA-DPB1 DDX5 CD3E CXCR4 PRKCH	5.38e-05	196	150	6	0f3c7fd450aaa1f866b8558692534c0ea2a34e75
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 ABCC9 GCG STT3A NID1	5.38e-05	196	150	6	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	Transplant_Alveoli_and_parenchyma-Immune-Dendritic_cells\|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X	RALA PDE4A BCL2L11 HLA-DPB1 SERPINF1 CXCR4	5.38e-05	196	150	6	f278b144b8deaee0bf41682081b9fbb0b1e82b19
ToppCell	Control-Lymphoid_T/NK-gd_T\|Control / Disease group, lineage and cell class	TTC16 CD3E PLPP2 CXCR4 SYNGR1 PRKCH	5.38e-05	196	150	6	98b11aada6bc5d928ef618573dc912d4d74a1092
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC16 HLA-DPB1 ZFYVE28 CD3E PRKCH RAB37	5.53e-05	197	150	6	ff34be81ee77efe60618641fa7c1084442b991d7
ToppCell	10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	GPC1 COL6A1 MYO1B HEPH TFPI SMARCA1	5.53e-05	197	150	6	c165c6fd12dc649b39e920d8528e2eb65c61956b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GPC1 PLEKHG7 CDHR1 FAM83F SYNGR1 NTN1	5.53e-05	197	150	6	107cb153ea7fc74bbd244dbb9d0499c0a8506724
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FAT4 ABCC9 MYO1B HEPH TFPI NID1	5.53e-05	197	150	6	2872a78b1be61aa1d50bc9a49294a21e922dc033
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC16 HLA-DPB1 CD3E CLIC1 PRKCH RAB37	5.53e-05	197	150	6	8e41e6cda38eace961cb1a56f4df24468c66b956
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	TTC16 DDX5 CD3E CXCR4 PRKCH RAB37	5.53e-05	197	150	6	e513d448385d5a8dbf68fb2b0892971cd841ae28
ToppCell	(2)_Fibroblasts-(22)_Fibro-3\|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis	PTX4 TTLL5 SERPINF1 SYNGR1 NID1 C1QTNF6	5.53e-05	197	150	6	d9021bab82403e566ec10f78acb227c0f80b88fe
ToppCell	NS-critical-d_16-33-Epithelial-Secretory\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GPC1 SERPINF1 PLPP2 PKP3 NTN1 CHPF	5.53e-05	197	150	6	a72047b7428c0d4aaf016c1ac23dc30919260fd8
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	GPC1 COL6A1 MYO1B MICAL2 NID1 PLXNA1	5.69e-05	198	150	6	8b9e8eaeffda40912a0163fdf39b93bc5e64751c
ToppCell	3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	GPC1 COL6A1 SERPINF1 TFPI NID1 MUSK	5.69e-05	198	150	6	38b37daf41d84e5bf913eb3f72963418b7c0aac6
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A1 SERPINF1 NID1 C1QTNF6 CHPF CRTAP	5.69e-05	198	150	6	1b90d632e59c3c47b936e829cceeb0334f05f34f
Drug	Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A	BCL2L11 SERPINF1 APBB2 TFPI TAF6L CXCR4 SOCS5 SERPINA5 PLXNA1	5.33e-06	192	150	9	2785_DN
Drug	MT19c compound	GPC1 PNMT MTERF1 SERPINF1 PGAP6 IFIT1 TRIM23 KCNRG FASN ARSA PKP3 GORAB TRIM47 CHPF	5.67e-06	498	150	14	ctd:C568376
Drug	Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	RALB COL6A1 AHI1 BCL2L11 MAP1A SGK2 CXCR4 MICAL2 MVB12B	6.57e-06	197	150	9	3723_DN
Disease	sleep duration, high density lipoprotein cholesterol measurement	PGS1 PNMT SLC12A4 DOCK6 MUSK CRBN	2.95e-05	121	144	6	EFO_0004612, EFO_0005271
Disease	Myasthenia Gravis	HLA-DPB1 MUSK	3.50e-04	6	144	2	C0026896
Disease	plasma serine protease inhibitor measurement	CYP4V2 SERPINA5	3.50e-04	6	144	2	EFO_0020642
Disease	response to gemcitabine, response to antineoplastic agent	PDE4D ALPK3	3.50e-04	6	144	2	GO_0036272, GO_0097327
Disease	Myasthenia Gravis, Ocular	HLA-DPB1 MUSK	3.50e-04	6	144	2	C0751340
Disease	Myasthenia Gravis, Generalized	HLA-DPB1 MUSK	3.50e-04	6	144	2	C0751339
Disease	Hereditary Motor and Sensory Neuropathy Type I	MORC2 FIG4	6.50e-04	8	144	2	C0751036
Disease	Roussy-Levy Syndrome (disorder)	MORC2 FIG4	6.50e-04	8	144	2	C0205713
Disease	Charcot-Marie-Tooth Disease, Type Ib	MORC2 FIG4	6.50e-04	8	144	2	C0270912
Disease	Charcot-Marie-Tooth Disease, Type Ia (disorder)	MORC2 FIG4	6.50e-04	8	144	2	C0270911
Disease	Osteogenesis imperfecta type IV (disorder)	SERPINF1 CRTAP	1.04e-03	10	144	2	C0268363
Disease	colorectal cancer (is_marker_for)	SERPINF1 GATA1 FASN CXCR4 AKT2	1.06e-03	157	144	5	DOID:9256 (is_marker_for)
Disease	Osteogenesis imperfecta type III (disorder)	SERPINF1 CRTAP	1.26e-03	11	144	2	C0268362
Disease	transient cerebral ischemia (is_implicated_in)	SERPINF1 TFPI	1.26e-03	11	144	2	DOID:224 (is_implicated_in)
Disease	Adenocarcinoma of large intestine	TNNI3K PRKCH AKT2 SMAD4	1.28e-03	96	144	4	C1319315
Disease	left ventricular systolic function measurement	MYO1C DNAJC18 ALPK3	1.30e-03	44	144	3	EFO_0008206
Disease	Charcot-Marie-Tooth Disease	MORC2 FIG4	1.51e-03	12	144	2	C0007959
Disease	Retinitis Pigmentosa	CYP4V2 AHI1 CDHR1 TULP1	1.71e-03	104	144	4	C0035334
Disease	Benign tumor of pancreas	AKT2 SMAD4	1.78e-03	13	144	2	C0347284
Disease	Osteogenesis Imperfecta	SERPINF1 CRTAP	1.78e-03	13	144	2	C0029434
Disease	level of Phosphatidylinositol (18:1_18:1) in blood serum	DOCK6 MUSK	1.78e-03	13	144	2	OBA_2045159
Disease	Hereditary Motor and Sensory-Neuropathy Type II	MORC2 FIG4	1.78e-03	13	144	2	C0270914
Disease	skin aging measurement	PEX3 PKD1L3 BRD1 MUSK PLXNA1	1.99e-03	181	144	5	EFO_0008006
Disease	Hypothermia, natural	GCG PRKCD	2.07e-03	14	144	2	C0020672
Disease	pancreatic adenocarcinoma (is_implicated_in)	RALB CXCR4	2.38e-03	15	144	2	DOID:4074 (is_implicated_in)
Disease	platelet crit	RALB PGS1 PDE4A AHI1 MAP1A SYF2 KDM6B CXCR4 TANGO2 RAB37 SMAD4 PGBD2	2.51e-03	952	144	12	EFO_0007985
Disease	osteosarcoma (is_implicated_in)	SERPINF1 CXCR4	2.71e-03	16	144	2	DOID:3347 (is_implicated_in)
Disease	central nervous system disease (implicated_via_orthology)	SMARCA5 SMARCA1	2.71e-03	16	144	2	DOID:331 (implicated_via_orthology)
Disease	omega-3 polyunsaturated fatty acid measurement	AHI1 CXCR4 DOCK6 MUSK	2.71e-03	118	144	4	EFO_0010119
Disease	alcohol use disorder (implicated_via_orthology)	CLIC6 KDM6B CLIC1 PRKCH AKT2	2.75e-03	195	144	5	DOID:1574 (implicated_via_orthology)
Disease	sphingomyelin 14:0 measurement	PDE4D NID1	3.07e-03	17	144	2	EFO_0010390
Disease	neutrophil count	AHI1 MYO1C BCL2L11 HLA-DPB1 MYO1B DPP8 KDM6B LCT CXCR4 MICAL2 VANGL1 GORAB RAB37 DOCK6 MUSK	3.17e-03	1382	144	15	EFO_0004833
Disease	pulse pressure measurement	COL6A1 MYO1C MTERF1 TTC16 ABCC9 KDM6B PKD1L3 DDX5 PPARGC1A FASN CD3E BRD1 MUSK SCAI KLB	3.39e-03	1392	144	15	EFO_0005763
Disease	non-alcoholic steatohepatitis (is_marker_for)	SERPINF1 SMAD4	3.44e-03	18	144	2	DOID:0080547 (is_marker_for)
Disease	level of Phosphatidylinositol (18:0_18:1) in blood serum	DOCK6 MUSK	3.44e-03	18	144	2	OBA_2045155
Disease	hepatocellular carcinoma (is_marker_for)	GPC1 SOX30 SERPINF1 TSC2 CXCR4 SMAD4	3.69e-03	301	144	6	DOID:684 (is_marker_for)
Disease	eosinophil percentage of leukocytes	BCL2L11 HLA-DPB1 GATA1 KDM6B TULP1 SDR9C7 CXCR4 C1QTNF6 CRBN CRTAP	3.71e-03	746	144	10	EFO_0007991
Disease	Pancreatic carcinoma	AKT2 SMAD4	3.83e-03	19	144	2	C0235974
Disease	low density lipoprotein cholesterol measurement, physical activity	CXCR4 MACO1 MUSK	4.16e-03	66	144	3	EFO_0003940, EFO_0004611
Disease	Mammary Carcinoma, Human	METTL6 CUL5 FASN CLIC1 CXCR4 AKT2 GNAI2 MED12	4.36e-03	525	144	8	C4704874
Disease	Mammary Neoplasms, Human	METTL6 CUL5 FASN CLIC1 CXCR4 AKT2 GNAI2 MED12	4.36e-03	525	144	8	C1257931
Disease	Seizures	RALA RARS1 TSC2 PRKCD PIGM	4.41e-03	218	144	5	C0036572
Disease	Mammary Neoplasms	METTL6 CUL5 FASN CLIC1 CXCR4 AKT2 GNAI2 MED12	4.46e-03	527	144	8	C1458155
Disease	type 2 diabetes mellitus (is_marker_for)	AHI1 SERPINF1 PPARGC1A AKT2	4.51e-03	136	144	4	DOID:9352 (is_marker_for)
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	PGS1 BCL2L11 MACO1 DOCK6 MUSK KLB	4.60e-03	315	144	6	EFO_0004612, EFO_0008591
Disease	Osteogenesis imperfecta	SERPINF1 CRTAP	4.67e-03	21	144	2	cv:C0029434
Disease	left atrial function	MGAT1 SIX5	4.67e-03	21	144	2	EFO_0004294
Disease	Deep Vein Thrombosis	TFPI PIGM	4.67e-03	21	144	2	C0149871
Disease	Venous Thrombosis	TFPI PIGM	4.67e-03	21	144	2	C0042487
Disease	level of Phosphatidylinositol (18:0_18:2) in blood serum	DOCK6 MUSK	4.67e-03	21	144	2	OBA_2045156
Disease	Liver Cirrhosis, Experimental	COL6A1 MYO1C SGK2 PLPP2 CLIC1 NID1 PRKCD GNAI2 SMAD4 CRTAP	4.80e-03	774	144	10	C0023893

Protein segments in the cluster

Peptide	Gene	Start	Entry
VRYSESFRNASSQEY	UMODL1	801	Q5DID0
AAARRRDSSHNELYY	VANGL1	331	Q8TAA9
VYAQVARYCNRSADL	BEST4	61	Q8NFU0
RARFYGAEIVSALEY	AKT2	251	P31751
YFYDGVSRDAASAAL	ERICH1	351	Q86X53
YNARDTVFYRAAVRL	BRD1	641	O95696
LDAEATARYNFYVKA	CDHR1	536	Q96JP9
LYNLQYFAERDATAA	ELMOD1	181	Q8N336
FLNYYADLETSAREL	APBB2	161	Q92870
NFEKAYLDSTERFYR	CUL5	201	Q93034
NVSEADDRYICDRFY	CXCR4	176	P61073
VVALYDYTANRSDEL	AHI1	1056	Q8N157
DFRAEAGILNYYRLD	ALKBH1	211	Q13686
YSAYEENNRTFLLAA	FAT4	3751	Q6V0I7
LYRCREEDAAIYQAS	ALPK3	341	Q96L96
RYIYNREEFARFDSD	HLA-DPB1	56	P04440
REAQFGTTAEIYAYR	CRBN	131	Q96SW2
GDEFNAYYARRVFLN	BCL2L11	156	O43521
FEATRSRNRYSVAYA	ABCC9	741	O60706
RYLNNAYARDEFTNT	CLIC6	671	Q96NY7
SLAQEAAFYARYRVD	ABHD16B	376	Q9H3Z7
LRNRIDQASLDYSYA	GORAB	206	Q5T7V8
DQASLDYSYARKRFD	GORAB	211	Q5T7V8
ELARDSYFYAVSDLQ	NTN1	266	O95631
GQEDYAAIRDNYFRS	RALA	71	P11233
GQEDYAAIRDNYFRS	RALB	71	P11234
DDFYDRLFDYRGRLS	RALY	121	Q9UKM9
RFRSVTHAYYRDAQA	RAB37	91	Q96AX2
DSYARFLRSNAYQDL	RGS6	436	P49758
EEFRSLASRYGDLYQ	INTS7	676	Q9NVH2
LASRYGDLYQASFDA	INTS7	681	Q9NVH2
EGVNAEVRYSFRYVD	PCDHGA12	271	O60330
ARFYYADEELNQVAA	ZFYVE28	21	Q9HCC9
YEGFYDVLRRNSQLA	FANCI	606	Q9NVI1
TADLDFFRRVRASYY	MAP1A	2706	P78559
LSYLQREAYDRDFLA	MGAT1	346	P26572
DKGRFELYRATFYAA	PRKCD	441	Q05655
YRVLLRYEGFENDAS	L3MBTL2	241	Q969R5
GELYTQNARAFRDLY	GPC1	131	P35052
DSQSRRYYFLSEEAE	HOOK2	171	Q96ED9
LDDVLYRYASFRNLV	LRRC75A	91	Q8NAA5
QYRTEELAQAYDAFT	KDM6B	1621	O15054
NTFRDRENYDRGYSS	DDX5	506	P17844
FIRSVYDSFRYQGLA	MACO1	61	Q8N5G2
LYEFLDFVDATDRYR	MFSD6L	271	Q8IWD5
AVAAYDYRGRTVVFA	PLXNA1	436	Q9UIW2
AAFATLVSDRFLRDY	NUP85	496	Q9BW27
QYYEDGARIEAAFRN	PGAM5	196	Q96HS1
NLSDSYFTNRQDRYV	PGS1	236	Q32NB8
QRRESFLYRSDSDYD	PDE4A	141	P27815
QRRESFLYRSDSDYD	PDE4D	186	Q08499
AEYIAQARRQYHFES	PEX3	46	P56589
GALRFYDRSDIDAVY	NID1	61	P14543
LRRTEAFADLFADYA	LCT	141	P09848
EFVQSAYLSRRLAYF	MED12	286	Q93074
RENSAAVQRAADYYS	GBP6	321	Q6ZN66
DYSKYLDSRRAQDFV	GCG	61	P01275
FSDYLRLQREALFYE	KCNRG	76	Q8N5I3
DAQRQDRPFFLYYAS	ARSA	211	P15289
VRRFFLVEASVYAYT	PGAP6	566	Q9HCN3
LVYTDRLYSRSDFNN	PLPP2	76	O43688
RLYSRSDFNNYVAAV	PLPP2	81	O43688
AYFLQRAGRDYAVFE	FOXRED2	46	Q8IWF2
RQLRYTDRDFYFASI	MIEF1	21	L0R8F8
EYEYSFRTEQSAAAR	MVB12B	291	Q9H7P6
YVRQDGTRSYFFTDD	METTL6	211	Q8TCB7
ERRSFRAYAAVLYID	MORC2	236	Q9Y6X9
YTLRRSNETDFELYF	PPARGC1A	736	Q9UBK2
AAAALAYYRDAEAYR	GATA1	56	P15976
TRAYLAYADNSRAQD	ATR	1401	Q13535
RQRENAIYSNDFDTY	C1QTNF6	251	Q9BXI9
DRVTYFDRNYGLRTF	DOCK6	1836	Q96HP0
AFSDSIRRELYYFGV	SDR9C7	181	Q8NEX9
VNDALGYVTRFYREA	COL6A1	916	P12109
RYYSNAFSDADRQDS	FIG4	576	Q92562
YESLFIRAVRAYNGE	CRTAP	206	O75718
EENRLYASYVSARAQ	CCDC166	71	P0CW27
YLASRYDFIDLDRVG	DPP8	736	Q6V1X1
RDFTFDLYRALASAA	SERPINA5	46	P05154
EDANFYLYLRARVCE	CD3E	106	P07766
AQSNDDSEYVRAVYR	CYP4V2	211	Q6ZWL3
ALEYYERALRLAADF	IFIT1	456	P09914
FSDLQQVSRIAAYAY	LAMTOR1	126	Q6IAA8
RNYYEILGVSRDASD	DNAJC18	81	Q9H819
AEDAARANSDRYAVY	EFNA2	26	O43921
AYTIRRGLFYVDFNS	KLB	471	Q86Z14
FERSVYSDRYIFASN	DCK	126	P27707
FYEDRAFQGRSYETT	CRYGC	6	P07315
YAGNIYRDLVSAFDV	DCST2	461	Q5T1A1
LDRQELSFAARSFYY	FASN	2411	P49327
SYRQDYALFLRFESV	CFAP47	361	Q6ZTR5
AYDQGIRYSFTFELR	CPB1	366	P15086
LSYAREAADFATNYQ	MICAL2	336	O94851
YNVSYNVDVRFRSLA	PTX4	66	Q96A99
SDRLARDYAAIVFFA	FIBP	166	O43427
YGETALLRAEADFYQ	KCTD11	51	Q693B1
DRGNTAAYLLYAFTR	RARS1	526	P54136
YRELYAFFGDSLATR	TAF6L	441	Q9Y6J9
CLEYADRALAFYAVR	TRIM47	551	Q96LD4
DLGFSDYAAAQLRQY	SYF2	121	O95926
ARFYAAEVASAIGYL	SGK2	136	Q9HBY8
NYAVDAYFREALRVS	SMARCA1	756	P28370
EDYLFSVSFRRYNRS	SOCS5	411	O75159
SFIAALTERAYYRSQ	PPP1R3E	16	Q9H7J1
FRDVYDYFRAVLQRD	FNTA	96	P49354
FGRSREYQLNDSAAY	GNAI2	141	P04899
AESFLYRNGENYRAD	HEPH	1006	Q9BQS7
YRNGENYRADVVDLF	HEPH	1011	Q9BQS7
AVFVQSYYLDREAGR	SMAD4	406	Q13485
RYRDDQDRFISFYEA	PKD1L3	1531	Q7Z443
YFNYRTTRFLAEEGF	STT3A	51	P46977
DGSRIIFDDFREAYY	STT3A	496	P46977
ALVAFQRGEYAELYR	SIX5	131	Q8N196
QAAESYYRALRVARD	SH3TC1	881	Q8TE82
AQAAFYYCERRRAAL	FAM83F	21	Q8NEG4
SRGIDYYDRNLALFE	SLC12A4	56	Q9UP95
GIFSTLNRDYSFRDY	SOX30	661	O94993
DYQALRTSIDAYDNF	CLTC	1476	Q00610
EACFYNSDYVAARGR	CHPF	676	Q8IZ52
VHRYLSNAYAREEFA	CLIC1	206	O00299
FEAFRLLAQYFEYRQ	CLVS2	66	Q5SYC1
FRRYIACVYLESNAD	PGBD2	516	Q6P3X8
ATSTYRAFAYERQAS	PKP3	206	Q9Y446
AAVASAYQRFEPRAY	PNMT	21	P11086
FGRVAEDAFTLDYRY	TULP1	506	O00294
AAVSNFGYDLYRVRS	SERPINF1	56	P36955
ILDLSNDYARRSYAN	MTERF1	281	Q99551
YLNEAFSFYSAIRQR	SCAI	146	Q8N9R8
RYQIGADSALFSQDY	SYNGR1	171	O43759
LGIEAFYFRNDSEYR	ZNF780A	111	O75290
LGLEAFYFRNDSEYR	ZNF780B	111	Q9Y6R6
FYFRNDSEYRSRFEG	ZNF780B	116	Q9Y6R6
ADRGLCRANENRFYY	TFPI	221	P10646
RDVFLNGSYNDYVRE	YTHDC1	581	Q96MU7
YVANDEEASYLRFRN	MTFR2	81	Q6P444
RDNDAFSYGYVRAEV	SLC30A7	91	Q8NEW0
FQGQLDYAEYVRRDS	TXNDC11	111	Q6PKC3
YLFRVNEATAVLYAR	ZZEF1	2606	O43149
AFAEGNYETAILRYS	TTC12	116	Q9H892
YSAAIFYLESLRQRD	PLEKHG7	396	Q6ZR37
FYLESLRQRDDFGIY	PLEKHG7	401	Q6ZR37
FLTAEESLYYFGERR	TPTE2	341	Q6XPS3
NRDSYFYAAIVAVVA	VMA21	61	Q3ZAQ7
TTNADVYIFRARLYN	TTC16	201	Q8NEE8
AENARSCIRAYFYDL	TRIM23	281	P36406
NYAVDAYFREALRVS	SMARCA5	741	O60264
RFELEYALNARSYAA	TNNI3K	766	Q59H18
RYTDIDYQVFTDAAR	PIGM	46	Q9H3S5
YEEGLARFATVRYDQ	TTLL5	241	Q6EMB2
LYRNFAAEQYASVFA	TSC2	856	P49815
NAYRLILAANRDEFY	TANGO2	16	Q6ICL3
EDPYSSRAARYVAFA	KCNC3	281	Q14003
FDEARARFYAAEIIS	PRKCH	451	P24723
ERDFSRYNYLSLDSA	MYO1B	226	O43795
YARDALAKAVYSRTF	MYO1C	376	O00159
ASYGRDAFAKAIYER	MYO1D	336	O94832
IADFGLSRNIYSADY	MUSK	741	O15146